BVF as of June 30, 2011
Portfolio Holdings for BVF
BVF holds 15 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rigel Pharmaceuticals | 30.4 | $52M | 5.7M | 9.17 | |
| Neurocrine Biosciences (NBIX) | 16.4 | $28M | 3.5M | 8.05 | |
| Ligand Pharmaceuticals In (LGND) | 14.7 | $25M | 2.1M | 11.95 | |
| Infinity Pharmaceuticals (INFIQ) | 12.3 | $21M | 2.6M | 8.26 | |
| Oncothyreon | 8.0 | $14M | 1.5M | 9.19 | |
| Flamel Technologies | 6.2 | $11M | 2.0M | 5.35 | |
| Pharmacyclics | 6.0 | $10M | 987k | 10.44 | |
| Palatin Technologies | 2.5 | $4.4M | 3.4M | 1.28 | |
| Targacept | 1.0 | $1.8M | 83k | 21.08 | |
| Capstone Therapeutics | 0.8 | $1.4M | 5.6M | 0.25 | |
| Ironwood Pharmaceuticals (IRWD) | 0.8 | $1.4M | 87k | 15.72 | |
| Osteologix (OLGX) | 0.3 | $605k | 1.6M | 0.37 | |
| ISIS Pharmaceuticals | 0.3 | $456k | 50k | 9.16 | |
| Cadus Corporation | 0.2 | $390k | 269k | 1.45 | |
| AutoImmune (AIMM) | 0.0 | $36k | 3.6M | 0.01 |
